Pediatric treatmentPediatric-onset multiple sclerosisRituximabMultiple sclerosis (MS) is the most common autoimmune, chronic inflammatory demyelinating disorder of the central nervous system. Pediatric-onset MS (POMS), as opposed to adult-onset MS (AOMS), is a rare condition, presenting similar clinical...
Multiple sclerosis (MS) is thought to be an autoimmune disease; however, the exact cause is not known. Early signs and symptoms of MS are fatigue, bladder and bowel problems, vision problems, and numbness, tingling, or pain in certain areas of the body.
Multiple sclerosis (MS) is thought to be an autoimmune disease; however, the exact cause is not known. Early signs and symptoms of MS are fatigue, bladder and bowel problems, vision problems, and numbness, tingling, or pain in certain areas of the body.
Multiple Sclerosis (MSC) TreatmentIntroducing Multiple Sclerosis Multiple Sclerosis (MSc) is an inflammatory demyelinating condition of the central nervous system that is mostly considered to be autoimmune. Uncertainty over the cause of this condition implies that it cannot realistically be prevented. ...
Treating multiple sclerosis costs a great deal for patients and communities. Individually, the nearly 1 million people with MS pay an average annual cost of more than $88,000 for the various treatment options, devices, daily living needs, and insurance needed for their condition. Overall, indirec...
Multiple Sclerosis Treatment There is no cure forMS, but several treatments can improve how you feel and keep your body working well. Your doctor can also prescribe drugs that may slow the course of the disease, prevent or treat attacks, ease your symptoms, or help you manage the stress that...
Causes of Multiple Sclerosis The causes of multiple sclerosis are still unclear. However, many scientists believe that MS is an autoimmune condition. In short, MS affects the healthy tissues inside the body, similar to how other autoimmune diseases work. To help patients and doctors, researchers ...
Immunomodulatory and immunosuppressive treatments for multiple sclerosis (MS) are associated with an increased risk of infection, which makes treatment of this condition challenging in daily clinical practice. Use of the expanding range of available drugs to treat MS requires extensive knowledge of treatme...
An actress's announcement that she is in remission from multiple sclerosis (MS), along with significant new treatment research, resulted in this week's top trending clinical topic. Selma Blair, 49, who was diagnosed with MS in 2018, announced that her "aggressive" treatment strategy was success...
Get the latest multiple sclerosis news, patient views, and caregiver perspectives from one of the largest MS communities online.